Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Outpatients With COVID-19
NCT04474483Phase 2Terminated
- Sponsor
- University at Buffalo
- Start
- Nov 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in coronavirus disease 2019 (COVID-19), sponsored by University at Buffalo. Started Nov 2020; status: terminated.
02
Drugs
melatonin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04474483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474483.